Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 19,174 shares at $18.09 ($347K) on 2024-02-07, disclosed to the SEC on 2024-02-09.
Scheduled sale ($347k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.09 | 9,587 | $173K | 50.0% |
| 2 | $18.09 | 9,587 | $173K | 50.0% |
| Total | $18.09 avg | 19,174 | $347K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |